Clinical Trial Update: Dendritic Cells in Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on dendritic cell therapy for non-small cell lung cancer; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Herlev Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED